Home
/
Century Therapeutics, Inc.
/
Financials
/
Quarterly
Century Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Century Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$109.16M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$109.16M
Aug 14, 2025
Q3
2025
Mar 31, 2025
$109.16M
Nov 13, 2025
Q2
2025
Mar 31, 2025
$109.16M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$109.16M
May 15, 2025
Q3
2025
Sep 30, 2024
$791.0K
Nov 13, 2025
Q2
2025
Jun 30, 2024
$771.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$855.0K
May 15, 2025
Q3
2024
Sep 30, 2023
$148.0K
Nov 5, 2024
Q2
2024
Jun 30, 2023
$99.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$1.72M
May 9, 2024
Q3
2023
Sep 30, 2022
$2.22M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$1.40M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$1.06M
May 11, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($34.42M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($32.54M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($32.54M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
$76.56M
May 15, 2025
Q2
2025
Mar 31, 2025
$76.56M
Aug 14, 2025
Q3
2025
Mar 31, 2025
$76.56M
Nov 13, 2025
Q3
2025
Sep 30, 2024
($31.23M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($31.21M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($31.21M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($28.06M)
May 15, 2025
Q2
2025
Mar 31, 2024
($28.06M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($28.06M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($32.72M)
Nov 5, 2024
Q3
2024
Jun 30, 2023
($33.29M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($33.29M)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($31.26M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($31.26M)
May 9, 2024
Q3
2024
Mar 31, 2023
($31.26M)
Nov 5, 2024
Q3
2023
Sep 30, 2022
($30.75M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($30.99M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($36.12M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($34.66M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
$74.18M
May 15, 2025
Q3
2025
Sep 30, 2024
($34.79M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($34.76M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($31.31M)
May 15, 2025
Q3
2024
Sep 30, 2023
($35.63M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
($35.08M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($32.08M)
May 9, 2024
Q3
2023
Sep 30, 2022
($31.74M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($31.35M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($37.44M)
May 11, 2023
Q3
2022
Sep 30, 2021
($25.83M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($23.02M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($18.06M)
May 16, 2022
Q3
2021
Sep 30, 2020
($13.13M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($15.52M)
Aug 12, 2021